Keynote Presentation
Topic: “Why Has AI Not Progressed in MSK as Much as It Should Have?”
Contributors:
(Each contributor: 2-minute opening statement followed by Q&A)
Jing Xie is the Senior Vice President, Global Regulatory and Clinical Affairs at MicroPort Orthopedics Inc. She joined MicroPort in September 2021 with over 20 years' experience in leading global teams and developing and executing clinical and regulatory strategies to accelerate market access and market development. Prior to joining MicroPort, Jing held multiple executive level positions, including Sr. Vice President, Global Clinical and Medical Affairs at Smith and Nephew, Vice President, Clinical, Regulatory and Office of Medical Affairs at Medtronic, Vice President, Clinical Affairs, Medical Device Innovation Consortium, Vice President, Global Clinical Affairs at Zimmer Biomet, and Vice President, Global Clinical Research at Biomet. She received her Bachelor of Science in Analytical Chemistry from Xiamen University, her Master of Science in Chemistry and Ph.D. in Materials Science from University of Alabama, and her Master of Science in Computer Science from Purdue University. She also attended the Global Leadership Program at the University of Notre Dame Mendozza College of Business.
